Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
MICROBIAL IMMUNOLOGY

High Levels of Serum Thromboxane B2 Are Generated during Human Pulmonary Dirofilariosis

R. Morchón, J. López-Belmonte, A. Rodríguez-Barbero, F. Simón
R. Morchón
1Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Salamanca, Avda. Campo Charro s/n 37007 Salamanca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. López-Belmonte
1Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Salamanca, Avda. Campo Charro s/n 37007 Salamanca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Rodríguez-Barbero
2Instituto Reina Sofia de Investigación Nefrológica, Departamento de Fisiología y Farmacología, Universidad de Salamanca, Campus Miguel de Unamuno 37007, Salamanca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Simón
1Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Salamanca, Avda. Campo Charro s/n 37007 Salamanca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fersimon@usal.es
DOI: 10.1128/CVI.00197-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The canine parasite Dirofilaria immitis can infect humans. Patients with pulmonary dirofilariosis develop significantly higher thromboxane B2 levels than healthy individuals living in areas where dirofilariosis is endemic and in areas where dirofilariosis is not endemic. The possible role of Wolbachia bacteria in the appearance of this eicosanoid is discussed.

Heartworm disease caused by Dirofilaria immitis in dogs and cats is distributed in temperate, subtropical, and tropical areas worldwide (7). The infection is transmitted by several mosquito species, most of which are able to feed on both animal reservoirs and humans. Thus, in areas of endemicity, people are at risk of infection. Human dirofilariosis is radiologically characterized by a solitary pulmonary calcified or noncalcified nodule (5, 15). These nodules appear when a migrating immature worm is trapped in a branch of the pulmonary artery and dies, causing coagulation necrosis with fibrosis and infiltration of inflammatory cells (8, 16). Wolbachia symbiont bacteria are a stable and abundant component of the bodies of many filarial species (2). In human D. immitis infections, high levels of immunoglobulin G (IgG) antibodies against the Wolbachia surface protein (WSP) have consistently been detected in patients with pulmonary dirofilariosis, while in healthy donors living in areas of endemicity, the levels of IgG anti-WSP are much lower (18). In addition, Wolbachia bacteria play an important role in the immunopathogenesis of both human filarial diseases (3, 19) and animal dirofilariosis (9). Eicosanoids are lipid mediators that regulate different physiological processes and modulate inflammatory and immunological responses in mammals (4). The effects of some of these eicosanoids antagonize the effects of others. Specifically, the thromboxanes (Txs) constrict blood vessels, suppress cyclic AMP, and promote platelet aggregation, while leukotrienes (LTs) are related to vascular permeability, chemotaxis, and polymorphonuclear leukocyte activation (17). Some of these lipid mediators have been observed in lymphatic filariae (10, 11, 13) and Onchocerca volvulus (4). Clinical studies have demonstrated high concentrations of TxB2 in the plasma of patients with septic and endotoxic shock (1) and in patients with chronic obstructive pulmonary disease (6).

The aim of this study was to investigate the levels of eicosanoids in the sera of patients with pulmonary dirofilariosis, a disease characterized by the inflammatory obstruction of pulmonary arteries and a disease in which the Wolbachia symbiont bacteria stimulate the immune systems of infected individuals.

Eighty human serum samples were divided into three groups. Group 1 (G1; n = 10) comprised serum samples from patients diagnosed with pulmonary dirofilariosis caused by D. immitis (these samples were kindly provided by Patrick Lammie from the Centers for Disease Control and Prevention, Atlanta, Ga.). These samples have high levels of specific IgG against WSP, as demonstrated previously (18). Group 2 (G2; n = 40) comprised serum samples from healthy individuals living in zones of endemicity in Spain and Italy with a positive serology (by enzyme-linked immunosorbent assay [ELISA]) for D. immitis antigens but without symptoms (healthy donors from areas of endemicity). Group 3 (G3; n = 30) comprised serum samples from healthy individuals living in an area of nonendemicity in Spain, where D. immitis infection in dogs and mosquitoes has not been recorded; these serum samples had a negative serology (by ELISA) for D. immitis and Wolbachia antigens (healthy controls). The levels of TxB2 and LTB4 in serum samples were analyzed by commercial ELISAs (R&D Systems). Briefly, serum samples were tested at 1:100 and 1:2 dilutions, respectively, for TxB2 and LTB4. The optical densities (ODs) at 405 nm were measured in an Easy Reader (Bio-Rad). The conversion of ODs to μg/ml was carried out by following the instructions of the manufacturers. The intra- and interassay precisions (coefficient of variation [CV]) ranged from 3.6 to 1.6% and from 7.7 to 6.2%, respectively, for TxB2. For LTB4, the CVs were 6.0 to 5.9% and 15.7 to 5.0%, respectively. The nonparametric Kruskal-Wallis test was used for multiple comparisons of the immunologic data. A significant difference was defined as a P value of <0.5, for a confidence level of 95%. For the paired samples, the Dunn test was used. In this case, a P value of <0.5 was considered significantly different.

The results are shown in Fig. 1. TxB2 levels were significantly higher in G1 than in G2 and G3 (P < 0.001). Significant differences in TxB2 levels were also observed between G2 and G3 (P < 0.001). Moderate LTB4 levels were observed only in healthy donors from areas of endemicity and not in individuals with pulmonary nodules or in healthy controls. Significant differences in LTB4 levels were detected between G2 and G3 and between G2 and G1 (P < 0.05) but not between G1 and G3.

Humans are not an adequate host for D. immitis. In fact, most infections are caused by larvae inoculated by infected mosquitoes. The positive serology for D. immitis antigens observed in these individuals reflects an active or recent infection, but only some infected individuals develop pulmonary nodules (14). Prostaglandin E2 has been detected in the microfilariae of Wuchereria bancrofti and Brugia malayi (12) and in Onchocerca volvulus adult worms (4). Its presence is related to the survival of parasites in immunocompetent hosts, due to the capacity of this eicosanoid to stimulate the Th2-type anti-inflammatory response. This is consistent with the detection, in our work, of moderate levels of LTB4 only in healthy individuals living in areas of endemicity and who had active or recent infections caused by migrating immature worms. The high levels of TxB2 observed in patients with pulmonary dirofilariosis are consistent with the events occurring during the formation of the nodules. Inflammation and obstruction of the arteries described in human dirofilariosis could be mediated by thromboxanes through their vasoconstriction and platelet aggregation stimulus. Another interesting fact is that antibodies against WSP of Wolbachia were previously detected only in patients with pulmonary nodules (18), indicating that the bacteria are released from the dying worm into the artery lumen. Because TxB2 has been detected during septic shock (1), we suggest that the production of this eicosanoid could be associated, in human dirofilariosis, with the release of Wolbachia bacteria during the formation of the nodules. More studies on the participation of these and other eicosanoids are needed to obtain a correct understanding of the regulation of the events that are conducive to the formation of pulmonary nodules during human pulmonary dirofilariosis.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Levels of TxB2 and LTB4 in serum samples from individuals in G1, G2, and G3.

ACKNOWLEDGMENTS

This work was supported by grant SAF2003-05829 from the Ministerio de Ciencia y Tecnología of Spain.

FOOTNOTES

    • Received 31 May 2006.
    • Returned for modification 7 July 2006.
    • Accepted 26 July 2006.
  • Copyright © 2006 American Society for Microbiology

REFERENCES

  1. 1.↵
    Ball, H. A., J. A. Cook, W. C. Wise, and P. V. Halushka. 1986. Role of thromboxane, prostaglandins and leukotrienes in endotoxic. Intensive Care Med.12:116-126.
    OpenUrlPubMedWeb of Science
  2. 2.↵
    Bandi, C., T. J. Anderson, C. Genchi, and M. L. Blaxter. 1998. Phylogeny of Wolbachia in filarial nematodes. Proc. Biol. Sci.265:2407-2413.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Brattig, N. W., U. Rathjens, M. Ernst, F. Geisinger, A. Renz, and F. W. Tischendorf. 2000. Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in the sequence of inflammatory and antiinflammatory responses of human monocytes. Microbes Infect.2:1147-1157.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Brattig, N. W., A. Schwohl, R. Rickert, and D. W. Buttner. 2006. The filarial parasite Onchocerca volvulus generates the lipid mediator prostaglandin E2. Microbes Infect.8:873-879.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Cordero, M., A. Muro, F. Simon, J. I. Tapia, and E. Espinoza. 1992. Are transient pulmonary solitary nodules a common event in human dirofilariosis? Clin. Investig.70:437-440.
    OpenUrlPubMed
  6. 6.↵
    Davi, G., S. Basili, M. Vieri, F. Cipollone, S. Santarone, C. Alessandri, P. Gazzaniga, C. Cordova, F. Violi, et al. 1997. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.156:1794-1799.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Genchi, C., L. H. Kramer, and G. Prieto. 2001. Epidemiology of canine and feline dirofilariosis. A global view, p. 121-129. In F. Simón and C. Genchi (ed.), Heartworm infection in humans and animals. Ediciones Universidad de Salamanca, Salamanca, Spain.
  8. 8.↵
    Hirano, H., T. Kizaki, T. Sashikata, and T. Matsumura. 2002. Pulmonary dirofilariosis—clinicopathological study. Kobe J. Med. Sci.48:79-86.
    OpenUrlPubMed
  9. 9.↵
    Kramer, L. H., F. Tamarozzi, R. Morchón, J. López-Belmonte, C. Marcos-Atxutegi, J. R. Martín-Pacho, and F. Simón. 2005. Immune response to and tissue localization of the Wolbachia surface protein (WSP) in dogs with natural heartworm (Dirofilaria immitis) infection. Vet. Immunol. Immunopathol.106:303-308.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Liu, L. X., and P. F. Weller. 1990. Arachidonic acid metabolism in filarial parasites. Exp. Parasitol.71:496-501.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Liu, L. X., C. N. Serhan, and P. F. Weller. 1990. Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids. J. Exp. Med.172:993-996.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Liu, L. X., J. E. Buhlmann, and P. F. Weller. 1992. Release of prostaglandin E2 by microfilariae of Wuchereria bancrofti and Brugia malayi. Am. J. Trop. Med. Hyg.46:520-523.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Longworth, D. L., D. W. Foster, A. M. Dvorak, and P. F. Weller. 1985. Incorporation of arachidonic acid by microfilariae of Brugia malayi. J. Infect. Dis.152:1317-1323.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Muro, A., C. Genchi, M. Cordero, and F. Simón. 1999. Human dirofilariasis in the European Union. Parasitol. Today15:386-389.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Navarrete, A. R. 1972. Pulmonary dirofilariasis. Chest61:51-54.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Robinson, M. J., M. Viamonte, and M. Viamonte. 1974. Dirolilariosis: diagnostic consideration for pulmonary coin lesions. South. Med. J.67:461.
    OpenUrlPubMed
  17. 17.↵
    Sala, A., and F. Gincarlo. 2001. Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation? Biochem. Biophys. Res. Commun.283:1003-1006.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Simon, F., G. Prieto, R. Morchon, C. Bazzocchi, C. Bandi, and C. Genchi. 2003. Immunoglobulin G antibodies against the endosymbionts of filarial nematodes (Wolbachia) in patients with pulmonary dirofilariasis. Clin. Diagn. Lab. Immunol.10:180-181.
    OpenUrlPubMed
  19. 19.↵
    Taylor, M. J., H. F. Cross, L. Ford, W. H. Makunde, G. B. K. S. Prasad, and K. Bilo. 2001. Wolbachia bacteria in filarial immunity and disease. Parasitol. Immunol.23:401-409.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
High Levels of Serum Thromboxane B2 Are Generated during Human Pulmonary Dirofilariosis
R. Morchón, J. López-Belmonte, A. Rodríguez-Barbero, F. Simón
Clinical and Vaccine Immunology Oct 2006, 13 (10) 1175-1176; DOI: 10.1128/CVI.00197-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
High Levels of Serum Thromboxane B2 Are Generated during Human Pulmonary Dirofilariosis
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High Levels of Serum Thromboxane B2 Are Generated during Human Pulmonary Dirofilariosis
R. Morchón, J. López-Belmonte, A. Rodríguez-Barbero, F. Simón
Clinical and Vaccine Immunology Oct 2006, 13 (10) 1175-1176; DOI: 10.1128/CVI.00197-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Dirofilariasis
Lung Diseases, Parasitic
Thromboxane B2

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X